对GIP受体的治疗向 - - 重温争议
Jonathan E Campbell1, Daniel J Drucker2
1Duke Molecular Physiology Institute, Durham, NC.
Diabetes
|June 16, 2025
概括
针对体重管理的双受体向显示出有希望. 结合葡萄糖类1受体 (GLP-1R) 和依赖葡萄糖的胰岛素型多受体 (GIPR) 调制,无论是通过激动作用还是通过对抗作用,都会产生类似的减肥效果.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗性减肥策略越来越多地涉及双受体向.
- 葡萄糖类1受体 (GLP-1R) 和依赖葡萄糖的胰岛素型多受体 (GIPR) 途径是关键目标.
- 目前的研究探讨了将GLP-1R激动性与GIPR激动性或对抗性结合起来.
研究的目的:
- 为了调和双受体向体重管理的看似矛盾的方法.
- 评估主要假设,解释相反的GIPR调制策略的类似减肥效应.
- 综合来自临床前,遗传和临床研究的证据.
主要方法:
- 临床前研究的审查和分析.
- 对人类遗传学数据的检查.
- 对临床试验结果的评估.
- 基于现有证据的点对点论证.
主要成果:
- 无论是GLP-1R激动因子与GIPR激动因子,还是GLP-1R激动因子与GIPR激动因子,都显示出显著的减肥效应.
- 尽管GIPR的机制相反,但联合疗法产生了可比的结果.
- 证据表明GLP-1R和GIPR信号在代谢调节中的复杂相互作用.
结论:
- 双重激发性 (GLP-1R/GIPR) 和GLP-1R激发性与GIPR对抗性代表了体重管理的可行的治疗策略.
- 需要进一步的研究,以充分阐明这些可比效应背后的机制.
- 了解这些受体相互作用对于优化未来的代谢疗法至关重要.
相关概念视频
Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438
G Protein-coupled Receptors
13.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.7K
Dipeptidyl Peptidase 4 Inhibitors
271
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
271
GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.9K
GPCR Desensitization
6.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.6K


